Apollo Therapeutics’ $226.5m Series C Financing

Taylor Wessing advised Apollo Therapeutics on its series C funding round.Apollo Therapeutics Limited, a biopharmaceutical company headquartered in Cambridge, has successfully raised $226.5 million in a…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Georgio Naffaa

This content is for Standard 1 Year members only.
Login Join Now